Next Article in Journal
MicroRNA-302b Enhances the Sensitivity of Hepatocellular Carcinoma Cell Lines to 5-FU via Targeting Mcl-1 and DPYD
Next Article in Special Issue
The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
Previous Article in Journal
Iron Oxide and Titanium Dioxide Nanoparticle Effects on Plant Performance and Root Associated Microbes
Previous Article in Special Issue
A Large-Scale Analysis of the Relationship of Synonymous SNPs Changing MicroRNA Regulation with Functionality and Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases

1
Department of Medicine, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA
2
Vascular Biology Center, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA
3
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2015, 16(10), 23651-23667; https://doi.org/10.3390/ijms161023651
Submission received: 25 August 2015 / Revised: 21 September 2015 / Accepted: 28 September 2015 / Published: 5 October 2015
(This article belongs to the Collection Regulation by Non-coding RNAs)

Abstract

Cardiovascular disease is the leading cause of death in the United States, accounting for nearly one in every seven deaths. Over the last decade, various targeted therapeutics have been introduced, but there has been no corresponding improvement in patient survival. Since the mortality rate of cardiovascular disease has not been significantly decreased, efforts have been made to understand the link between heart disease and novel therapeutic targets such as non-coding RNAs. Among multiple non-coding RNAs, long non-coding RNA (lncRNA) has emerged as a novel therapeutic in cardiovascular medicine. LncRNAs are endogenous RNAs that contain over 200 nucleotides and regulate gene expression. Recent studies suggest critical roles of lncRNAs in modulating the initiation and progression of cardiovascular diseases. For example, aberrant lncRNA expression has been associated with the pathogenesis of ischemic heart failure. In this article, we present a synopsis of recent discoveries that link the roles and molecular interactions of lncRNAs to cardiovascular diseases. Moreover, we describe the prevalence of circulating lncRNAs and assess their potential utilities as biomarkers for diagnosis and prognosis of heart disease.
Keywords: chromatin; epigenetic regulation; gene regulation; heart disease; non-coding RNAs chromatin; epigenetic regulation; gene regulation; heart disease; non-coding RNAs
Graphical Abstract

Share and Cite

MDPI and ACS Style

Archer, K.; Broskova, Z.; Bayoumi, A.S.; Teoh, J.-p.; Davila, A.; Tang, Y.; Su, H.; Kim, I.-m. Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases. Int. J. Mol. Sci. 2015, 16, 23651-23667. https://doi.org/10.3390/ijms161023651

AMA Style

Archer K, Broskova Z, Bayoumi AS, Teoh J-p, Davila A, Tang Y, Su H, Kim I-m. Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases. International Journal of Molecular Sciences. 2015; 16(10):23651-23667. https://doi.org/10.3390/ijms161023651

Chicago/Turabian Style

Archer, Krystal, Zuzana Broskova, Ahmed S. Bayoumi, Jian-peng Teoh, Alec Davila, Yaoliang Tang, Huabo Su, and Il-man Kim. 2015. "Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases" International Journal of Molecular Sciences 16, no. 10: 23651-23667. https://doi.org/10.3390/ijms161023651

APA Style

Archer, K., Broskova, Z., Bayoumi, A. S., Teoh, J.-p., Davila, A., Tang, Y., Su, H., & Kim, I.-m. (2015). Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases. International Journal of Molecular Sciences, 16(10), 23651-23667. https://doi.org/10.3390/ijms161023651

Article Metrics

Back to TopTop